Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early low-dose dexamethasone for adults hospitalized with influenza-like illness during a pandemic
2013-001051-12Phase 3
- Sponsor
- Nottingham University Hospitals
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in influenza and influenza-like illness (ILI) comparing Dexsol plus standard care with Placebo plus standard care (2 arms). Primary endpoint: Admission to intensive care unit or death within 30 days.
02
Drugs
dexamethasone
03
Conditions
influenzainfluenza-like illness (ILI)
Beyond the preview
Go deeper on 2013-001051-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001051-12.